Esophageal Adenosquamous Carcinoma
Associated Genetic Biomarkers
NCI Definition: An esophageal carcinoma characterized by the presence of distinguishable squamous and glandular carcinomatous components. 
There are 3 clinical trials for esophageal adenosquamous carcinoma, of which 3 are open and 0 are completed or closed. Of the trials that contain esophageal adenosquamous carcinoma as an inclusion criterion, 1 is phase 1 (1 open), 1 is phase 2 (1 open), and 1 is phase 3 (1 open).
Adavosertib, carboplatin, and cisplatin are the most common interventions in esophageal adenosquamous carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.